Stanley Druckenmiller's position in SpringWorks Therapeutics is currently worth $28.9 Million. That's 0.84% of their equity portfolio (30th largest holding). The first SpringWorks Therapeutics trade was made in Q2 2024. Since then Stanley Druckenmiller bought shares one more times and sold shares on two occasions. The stake costed the investor $25.4 Million, netting the investor a gain of 14% so far.